Sort by
Items per page

Send to

Choose Destination

Best matches for Agustí A[au]:

After asthma: redefining airways diseases. Pavord ID et al. Lancet. (2018)

The microbiome in respiratory medicine: current challenges and future perspectives. Faner R et al. Eur Respir J. (2017)

Precision medicine in airway diseases: moving to clinical practice. Agustí A et al. Eur Respir J. (2017)

Search results

Items: 1 to 50 of 533


Current Controversies in Chronic Obstructive Pulmonary Disease: A Report from the GOLD Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2018 Nov 14. doi: 10.1513/AnnalsATS.201808-557PS. [Epub ahead of print] No abstract available.


Do we really need a new classification of airway diseases?

Agusti A, Pavord ID.

Lancet Respir Med. 2018 Nov 9. pii: S2213-2600(18)30386-2. doi: 10.1016/S2213-2600(18)30386-2. [Epub ahead of print] No abstract available.


Lessons from a Life: The Manuel Tapia Lecture 2018.

Agusti A.

Arch Bronconeumol. 2018 Nov 2. pii: S0300-2896(18)30336-3. doi: 10.1016/j.arbres.2018.09.003. [Epub ahead of print] English, Spanish. No abstract available.


The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study.

Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK.

J Epidemiol. 2018 Oct 20. doi: 10.2188/jea.JE20180039. [Epub ahead of print]


The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2018 Oct 18. pii: S0300-2896(18)30329-6. doi: 10.1016/j.arbres.2018.07.026. [Epub ahead of print] English, Spanish.


INTEND II randomized clinical trial of intraoperative duct endoscopy in pathological nipple discharge.

Gui G, Agusti A, Twelves D, Tang S, Kabir M, Montgomery C, Nerurkar A, Osin P, Isacke C.

Br J Surg. 2018 Nov;105(12):1583-1590. doi: 10.1002/bjs.10990. Epub 2018 Sep 20.


Inhaled corticosteroids in COPD: Friend or foe?

Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FM, Rabe KF, Papi A.

Eur Respir J. 2018 Sep 6. pii: 1801219. doi: 10.1183/13993003.01219-2018. [Epub ahead of print] Review.


Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.


The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD.

Obeidat M, Dvorkin-Gheva A, Li X, Bossé Y, Brandsma CA, Nickle DC, Hansbro PM, Faner R, Agusti A, Paré PD, Stampfli MR, Sin DD.

Sci Rep. 2018 Aug 8;8(1):11881. doi: 10.1038/s41598-018-30313-z.


Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.

Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A.

ERJ Open Res. 2018 Aug 3;4(3). pii: 00022-2018. doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.


The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model.

Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, Donaire-Gonzalez D, Ferrer J, Rodríguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J; and the PAC-COPD Study Group.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800079. doi: 10.1183/13993003.00079-2018. Print 2018 Sep.


Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD.

López-Giraldo A, Cruz T, Molins L, Guirao Á, Saco A, Cuerpo S, Ramirez J, Agustí Á, Faner R.

BMC Pulm Med. 2018 Jul 31;18(1):123. doi: 10.1186/s12890-018-0688-3.


Whole exome sequencing analysis in severe chronic obstructive pulmonary disease.

Qiao D, Ameli A, Prokopenko D, Chen H, Kho AT, Parker MM, Morrow J, Hobbs BD, Liu Y, Beaty TH, Crapo JD, Barnes KC, Nickerson DA, Bamshad M, Hersh CP, Lomas DA, Agusti A, Make BJ, Calverley PMA, Donner CF, Wouters EF, Vestbo J, Paré PD, Levy RD, Rennard SI, Tal-Singer R, Spitz MR, Sharma A, Ruczinski I, Lange C, Silverman EK, Cho MH.

Hum Mol Genet. 2018 Nov 1;27(21):3801-3812. doi: 10.1093/hmg/ddy269.


Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.

Faner R, Noell G, Badia JR, López-Giraldo A, Bakke P, Silverman EK, Tal-Singer R, Agustí A.

Respir Med. 2018 Aug;141:14-19. doi: 10.1016/j.rmed.2018.06.015. Epub 2018 Jun 19.


Precision medicine in COPD exacerbations.

Agusti A, Faner R, Celli B, Rodriguez-Roisin R.

Lancet Respir Med. 2018 Sep;6(9):657-659. doi: 10.1016/S2213-2600(18)30296-0. Epub 2018 Jul 18. No abstract available.


How to Define Early Chronic Obstructive Pulmonary Disease.

Agusti A, Faner R.

Am J Respir Crit Care Med. 2018 Oct 1;198(7):973. doi: 10.1164/rccm.201805-0880LE. No abstract available.


Bone marrow characterization in COPD: a multi-level network analysis.

Toledo-Pons N, Noell G, Jahn A, Iglesias A, Duran MA, Iglesias J, Rios A, Scrimini S, Faner R, Gigirey O, Agustí A, Cosío BG.

Respir Res. 2018 Jun 15;19(1):118. doi: 10.1186/s12931-018-0824-x.


Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?

Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011. doi: 10.1164/rccm.201801-0095PP. No abstract available.


Correction to: Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.

Olloquequi J, Jaime S, Parra V, Cornejo-Córdova E, Valdivia G, Agustí À, Silva RO.

Respir Res. 2018 Apr 30;19(1):77. doi: 10.1186/s12931-018-0765-4.


COPD: time to improve its taxonomy?

Celli BR, Agustí A.

ERJ Open Res. 2018 Feb 16;4(1). pii: 00132-2017. doi: 10.1183/23120541.00132-2017. eCollection 2018 Jan.


The Changing Landscape of Chronic Obstructive Pulmonary Disease.

Agustí A, Faner R.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):978-981. doi: 10.1164/rccm.201804-0714ED. No abstract available.


Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease.

Rodríguez-Roisin R, Krowka MJ, Agustí A.

Compr Physiol. 2018 Mar 25;8(2):711-729. doi: 10.1002/cphy.c170020.


Pharmacological treatment of COPD: the devil is always in the detail.

Singh D, Barnes PJ, Stockley R, Lopez Valera MV, Vogelmeier C, Agusti A.

Eur Respir J. 2018 Apr 19;51(4). pii: 1800263. doi: 10.1183/13993003.00263-2018. Print 2018 Apr. No abstract available.


The disease model: implications for clinical practice.

Agusti A.

Eur Respir J. 2018 Apr 12;51(4). pii: 1800188. doi: 10.1183/13993003.00188-2018. Print 2018 Apr. No abstract available.


Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function.

Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, Romaní-Pérez M, Sanz Y.

Front Neurosci. 2018 Mar 16;12:155. doi: 10.3389/fnins.2018.00155. eCollection 2018. Review.


COPD beyond smoking: new paradigm, novel opportunities.

Agustí A, Faner R.

Lancet Respir Med. 2018 May;6(5):324-326. doi: 10.1016/S2213-2600(18)30060-2. Epub 2018 Feb 26. No abstract available.


Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee.

Fuentes Camps I, Rodríguez A, Agustí A.

Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22.


Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.

Celli BR, Locantore N, Tal-Singer R, Riley J, Miller B, Vestbo J, Yates JC, Silverman EK, Owen CA, Divo M, Pinto-Plata V, Wouters EFM, Faner R, Agusti A; ECLIPSE Study Investigators.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702146. doi: 10.1183/13993003.02146-2017. Print 2018 Feb.


From systems biology to P4 medicine: applications in respiratory medicine.

Noell G, Faner R, Agustí A.

Eur Respir Rev. 2018 Feb 7;27(147). pii: 170110. doi: 10.1183/16000617.0110-2017. Print 2018 Mar 31. Review.


Filling the gaps in COPD: the TRIBUTE study.

Agusti A.

Lancet. 2018 Mar 17;391(10125):1004-1006. doi: 10.1016/S0140-6736(18)30252-6. Epub 2018 Feb 9. No abstract available. Erratum in: Lancet. 2018 Feb 14;:.


Pulmonary function predicts mortality and hospitalizations in outpatients with heart failure and preserved ejection fraction.

Andrea R, López-Giraldo A, Falces C, López T, Sanchis L, Gistau C, Sabaté M, Sitges M, Brugada J, Agustí À.

Respir Med. 2018 Jan;134:124-129. doi: 10.1016/j.rmed.2017.12.004. Epub 2017 Dec 6.


Hospitalizations due to exacerbations of COPD: A big data perspective.

Serra-Picamal X, Roman R, Escarrabill J, García-Altés A, Argimón JM, Soler N, Faner R, Carbonell EM, Trilla A, Agusti A.

Respir Med. 2018 Jan 16. pii: S0954-6111(18)30009-X. doi: 10.1016/j.rmed.2018.01.008. [Epub ahead of print]


Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.

Alcázar-Navarrete B, Ruiz Rodríguez O, Conde Baena P, Romero Palacios PJ, Agusti A.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701457. doi: 10.1183/13993003.01457-2017. Print 2018 Jan.


Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.

Olloquequi J, Jaime S, Parra V, Cornejo-Córdova E, Valdivia G, Agustí À, Silva O R.

Respir Res. 2018 Jan 18;19(1):13. doi: 10.1186/s12931-018-0718-y. Erratum in: Respir Res. 2018 Apr 30;19(1):77.


Clinical News.

Hosgood S, Williams R, Brugada J, Agusti A, Faner R, Noell G.

Br J Hosp Med (Lond). 2018 Jan 2;79(1):8-11. doi: 10.12968/hmed.2018.79.1.8. No abstract available.


Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment.

Giménez-Garzó C, Urios A, Agustí A, Mangas-Losada A, García-García R, Escudero-García D, Kosenko E, Ordoño JF, Tosca J, Giner-Durán R, Serra MA, Felipo V, Montoliu C.

Free Radic Res. 2018 Jan;52(1):118-133. doi: 10.1080/10715762.2017.1420183.


Natural history of COPD: gaps and opportunities.

Agustí A, Celli B.

ERJ Open Res. 2017 Dec 14;3(4). pii: 00117-2017. doi: 10.1183/23120541.00117-2017. eCollection 2017 Oct.


Towards a global initiative for fibrosis treatment (GIFT).

Molina-Molina M, Agusti A, Crestani B, Schwartz DA, Königshoff M, Chambers RC, Maher TM, Faner R, Mora AL, Rojas M, Antoniou KM, Sellares J.

ERJ Open Res. 2017 Dec 1;3(4). pii: 00106-2017. doi: 10.1183/23120541.00106-2017. eCollection 2017 Oct.


Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.


Lung function in early adulthood and health in later life: a transgenerational cohort analysis.

Agustí A, Noell G, Brugada J, Faner R.

Lancet Respir Med. 2017 Dec;5(12):935-945. doi: 10.1016/S2213-2600(17)30434-4. Epub 2017 Nov 14.


COPD: algorithms and clinical management.

Faner R, Agustí A.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701733. doi: 10.1183/13993003.01733-2017. Print 2017 Nov. No abstract available.


Endosulfan and Cypermethrin Pesticide Mixture Induces Synergistic or Antagonistic Effects on Developmental Exposed Rats Depending on the Analyzed Behavioral or Neurochemical End Points.

Gómez-Giménez B, Llansola M, Cabrera-Pastor A, Hernández-Rabaza V, Agustí A, Felipo V.

ACS Chem Neurosci. 2018 Feb 21;9(2):369-380. doi: 10.1021/acschemneuro.7b00364. Epub 2017 Nov 13.


Precision medicine in airway diseases: moving to clinical practice.

Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, Louis R, McDonald VM, Sterk PJ, Thomas M, Vogelmeier C, Pavord ID; on behalf of all participants in the seminar.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701655. doi: 10.1183/13993003.01655-2017. Print 2017 Oct.


The EASI model: A first integrative computational approximation to the natural history of COPD.

Agustí A, Compte A, Faner R, Garcia-Aymerich J, Noell G, Cosio BG, Rodriguez-Roisin R, Celli B, Anto JM.

PLoS One. 2017 Oct 10;12(10):e0185502. doi: 10.1371/journal.pone.0185502. eCollection 2017.


Developmental Exposure to Pesticides Alters Motor Activity and Coordination in Rats: Sex Differences and Underlying Mechanisms.

Gómez-Giménez B, Felipo V, Cabrera-Pastor A, Agustí A, Hernández-Rabaza V, Llansola M.

Neurotox Res. 2018 Feb;33(2):247-258. doi: 10.1007/s12640-017-9823-9. Epub 2017 Oct 3.


Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare.

Mestres C, Agustí A, Hernandez M, Puerta L, Llagostera B.

Pharmacy (Basel). 2017 May 19;5(2). pii: E27. doi: 10.3390/pharmacy5020027.


Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.


Bifidobacterium pseudocatenulatum CECT 7765 Ameliorates Neuroendocrine Alterations Associated with an Exaggerated Stress Response and Anhedonia in Obese Mice.

Agusti A, Moya-Pérez A, Campillo I, Montserrat-de la Paz S, Cerrudo V, Perez-Villalba A, Sanz Y.

Mol Neurobiol. 2018 Jun;55(6):5337-5352. doi: 10.1007/s12035-017-0768-z. Epub 2017 Sep 18.


After asthma: redefining airways diseases.

Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A.

Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11. Review. No abstract available.


Spirometrically Confirmed Chronic Obstructive Pulmonary Disease Worsens Long-Term Prognosis after Percutaneous Coronary Intervention.

Almagro P, De la Sierra A, Acosta E, Navarro A, Garcia ME, Valdivieso S, Castañeda T, Agustí A.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):824-826. doi: 10.1164/rccm.201707-1389LE. No abstract available.


Supplemental Content

Loading ...
Support Center